Stay updated on Tipifarnib and Alpelisib in R/M HNSCC Clinical Trial
Sign up to get notified when there's something new on the Tipifarnib and Alpelisib in R/M HNSCC Clinical Trial page.

Latest updates to the Tipifarnib and Alpelisib in R/M HNSCC Clinical Trial page
- Check6 days agoChange DetectedThe clinical trial record for the tipifarnib–alpelisib study is displayed, with details on its completed status, participant criteria, study sites, outcome measures, and study documents.SummaryDifference64%

- Check13 days agoChange DetectedThe footer revision identifier changes from v3.7.2 to v3.8.0 while the page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check20 days agoNo Change Detected
- Check27 days agoChange DetectedAn NIH-wide notice about the transition from “Artificial Intelligence” to “Super Intelligence” appears above the page, and the footer revision changes from v3.7.1 to v3.7.2.SummaryDifference1%

- Check41 days agoChange DetectedThe footer revision changed from v3.7.0 to v3.7.1.SummaryDifference0.2%

- Check55 days agoChange DetectedThe page now displays a 403 Forbidden error, indicating an access restriction that prevents viewing the study details.SummaryDifference20%

- Check62 days agoChange Detected- The page now displays Revision: v3.7.0, replacing Revision: v3.6.6. This indicates a version update to the page; no user-facing study content appears to have changed.SummaryDifference0.0%

Stay in the know with updates to Tipifarnib and Alpelisib in R/M HNSCC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Tipifarnib and Alpelisib in R/M HNSCC Clinical Trial page.